Alzheimer's Association calls for accelerated approval of new drug
The Alzheimer's Association is calling for the FDA to accelerate approval of a new drug to treat the disease. New data shows the experimental medication modestly slowed the progression of Alzheimer's, but critics question if the benefits are worth the risks. Jarred Hill reports for CBS2.